What is the release reviewer expected to decide?
Identify the legal entity and quality role responsible for the applicable release decision, then distinguish that decision from the buyer’s commercial receipt. The release dossier should identify the material, lot, effective specification and manufacturing site. Ask which supporting records are routinely included, which must be requested and who retains the originals. FDA’s quality-agreement guidance addresses responsibilities in contract drug manufacturing and provides context for agreeing those boundaries.
FDA (2016) · Quality agreements in contract drug manufacturing


Which open records can affect the lot?
Cross-reference the lot to any relevant deviations, changes, analytical amendments and commitments from the transfer review. Record the status of each item at the time release is being considered. A certificate of analysis can state reported results while leaving a connected investigation in a separate file. The buyer and responsible quality reviewer should know how that file is retrieved and who can interpret its impact.
How is a partial delivery represented?
Suppose one purchase order is split across two finished lots and only the first lot has a complete dossier. Identify the eligible lot, quantity and physical shipment explicitly. Preserve the separate status of the second lot in the purchasing system and warehouse instructions. An order-level message that says “released” can otherwise be applied to both. Ask the designated reviewer to record the effective decision and reference the evidence set used for that particular lot.
Worked example
A release package can arrive with complete signatures but an omitted attachment cited by the reviewer. Identify the missing document number, revision and reviewer who relies on it. Ask the authorised quality owner to record the disposition before purchasing treats the delivery as accepted.
Prepare your inquiry
Record release against the identified lot and its evidence, even when the purchase order covers more material.